Method for drying and producing microporous particles
    1.
    发明授权
    Method for drying and producing microporous particles 有权
    干燥和生产微孔颗粒的方法

    公开(公告)号:US06516537B1

    公开(公告)日:2003-02-11

    申请号:US09623856

    申请日:2000-09-11

    IPC分类号: F26B300

    摘要: In a process for drying microporous, fluid-containing particles, the fluid-containing particles to be dried are fed as a moving bed countercurrently to a drying fluid, the interfacial tension of the fluid being reduced in comparison with the interfacial tension of the fluid at room temperature, at near-critical to supercritical pressure of the fluid, preferably to a value in the range from 0 to {fraction (1/10)}, in particular from 0 to {fraction (1/20)}, of the interfacial tension at room temperature. Furthermore, microporous, three-dimensionally networked particles are prepared by a process comprising preparation of microporous particles containing pore liquid, exchange of the pore liquid in the particles for a fluid and drying of the fluid-containing particles, the exchange and drying being carried out in the moving bed by the countercurrent method.

    摘要翻译: 在微孔,含流体颗粒的干燥过程中,要干燥的含流体颗粒作为移动床与干燥流体逆流进料,与流体的界面张力相比,流体的界面张力相对于 在室温附近,液体的临界压力接近临界压,优选为室温下界面张力的0至1/10,特别是0至1/20的值。 此外,通过包括制备包含孔隙液体的微孔颗粒,交换颗粒中的孔隙液体用于流体并干燥含流体的颗粒,进行交换和干燥的方法制备微孔,三维网状颗粒 在移动床上采用逆流法。

    Method for drying and producing microporous particles and a drying device
    2.
    发明授权
    Method for drying and producing microporous particles and a drying device 有权
    干燥和生产微孔颗粒的方法和干燥装置

    公开(公告)号:US06438867B1

    公开(公告)日:2002-08-27

    申请号:US09623873

    申请日:2000-09-11

    IPC分类号: F26B300

    CPC分类号: F26B7/00

    摘要: In a process for drying microporous, fluid-containing particles, the heat required for increasing the temperature is supplied by convection by reducing the interfacial tension of the fluid, preferably to 0 to 1/10, in particular to 0 to 1/20, of the interfacial tension of the fluid at room temperature, by appropriately increasing the temperature at from close to the critical pressure to supercritical pressure of the fluid. Furthermore, microporous, three-dimensionally networked particles are prepared by a process in which the drying process is used. In addition, an apparatus is used for carrying out the drying process, the apparatus comprising a pressure container having an inner container and pressure-withstanding outer container and suitable measuring and control apparatuses and pump apparatuses and heat exchangers, the inner container being provided for holding the particles to be dried and a gap being provided between the inner container and the outer container.

    摘要翻译: 在微孔,含流体颗粒的干燥过程中,通过降低流体的界面张力,优选为0至1/10,特别是0至1/20,通过对流来提供增加温度所需的热量 流体在室温下的界面张力,通过将接近临界压力的温度适当地提高到流体的超临界压力。 此外,通过使用干燥方法的方法制备微孔,三维网状颗粒。 此外,使用装置进行干燥处理,该装置包括具有内部容器和耐压外部容器的压力容器以及合适的测量和控制装置以及泵装置和热交换器,所述内部容器设置用于保持 待干燥的颗粒和在内部容器和外部容器之间设置的间隙。

    Semiconductor memory having redundancy circuit
    4.
    发明授权
    Semiconductor memory having redundancy circuit 失效
    具有冗余电路的半导体存储器

    公开(公告)号:US6078534A

    公开(公告)日:2000-06-20

    申请号:US937570

    申请日:1997-09-25

    IPC分类号: G11C29/04 G11C29/00 G11C7/00

    CPC分类号: G11C29/789 G11C29/80

    摘要: A memory having an array of memory cells. The array includes a plurality of normal memory cells and a redundant memory cell. A decoder is provided for selecting an addressed one of the normal memory cells in response to an address and a normal condition signal and adapted address the redundant memory cell in response to the address and a fault condition signal. A redundant decoder is provided having an electronically erasable read-only-memory cell. The redundant decoder is adapted to produce the normal condition signal and to convert the normal condition signal into the fault condition signal when such read-only-memory cell is programmed into a fault condition. Each one of the read-only memory cells include a flash memory cell, a ferroelectric memory cell, or other such type of electronically erasable read-only memory cell which is substantially non-volatile and is able to retain its programmed state for a relatively long period of time. With such an arrangement, because the electronically erasable read-only-memory cell is electronically programmable, a defective normal memory cell may be replaced with a redundant memory cell the memory is packaged.

    摘要翻译: 具有存储器单元阵列的存储器。 阵列包括多个正常存储器单元和冗余存储单元。 提供了一种解码器,用于响应于地址和正常条件信号选择正常存储器单元中的寻址的一个,并响应于该地址和故障状态信号对该冗余存储器单元进行了适配地址。 提供了具有电可擦除只读存储器单元的冗余解码器。 当这种只读存储器单元被编程到故障状态时,冗余解码器适于产生正常条件信号并将正常条件信号转换成故障条件信号。 只读存储器单元中的每一个包括快闪存储器单元,铁电存储器单元或其他这种类型的电可擦除只读存储器单元,其基本上是非易失性的并且能够将其编程状态保持相对较长 一段的时间。 通过这样的布置,由于电子可擦除只读存储器单元是可电子编程的,所以可以用存储器封装的冗余存储器单元替换有缺陷的正常存储单元。

    1-(.alpha.-Amino-.alpha.-phenyl-o-tolyl)imidazoles
    6.
    发明授权
    1-(.alpha.-Amino-.alpha.-phenyl-o-tolyl)imidazoles 失效
    1 - ({60-氨基 - {60-苯基 - 邻甲苯基)咪唑

    公开(公告)号:US4020085A

    公开(公告)日:1977-04-26

    申请号:US681184

    申请日:1976-04-28

    申请人: Martin Gall

    发明人: Martin Gall

    摘要: 3-Substituted 4-(.alpha.-amino-.alpha.-phenyl-o-tolyl)-4H-1,2,4-triazoles, 2-substituted 1-(.alpha.amino-.alpha.-phenyl-o-tolyl)imidazoles, pharmacologically acceptable acid addition salts thereof and processes for their production. The compounds of this invention and the pharmacologically acceptable acid addition salts thereof are useful as sedatives, hypnotics, anticonvulsants, tranquilizers, and muscle relaxants. They are also useful as feed additives for increasing growth rate and feed efficiency of livestock and poultry.

    摘要翻译: 3-取代的4-(α-氨基-α-苯基 - 邻甲苯基)-4H-1,2,4-三唑,2-取代的1-(α氨基-α-苯基 - 邻 - 甲苯基)咪唑,药理学上可接受的 其酸加成盐及其制备方法。 本发明的化合物及其药理学上可接受的酸加成盐可用作镇静剂,催眠药,抗惊厥药,镇静剂和肌肉松弛剂。 它们也可用作增加牲畜和家禽生长速度和饲料效率的饲料添加剂。

    [3-Substituted-5-[(di-methylamino)methyl]-4H-1,2,4-triazol-
4-yl]benzophenones and process
    7.
    发明授权
    [3-Substituted-5-[(di-methylamino)methyl]-4H-1,2,4-triazol- 4-yl]benzophenones and process 失效
    {8,3-取代的5- {8(二甲基氨基)甲基{9 -4 H-1,2,4-三唑-4-基} {9二苯甲酮和方法

    公开(公告)号:US4010177A

    公开(公告)日:1977-03-01

    申请号:US584616

    申请日:1975-06-06

    申请人: Martin Gall

    发明人: Martin Gall

    摘要: Compounds of the formula I: ##STR1## wherein R.sub.1 is hydroxymethyl, or -CH.sub.2 NR.sub.6 R.sub.7, in which R.sub.6 is -CH.sub.2 -C.tbd.CH, -CH.sub.2 -CH=CH.sub.2, ##STR2## or alkyl of 1 to 3 carbon atoms, inclusive; R.sub.7 is hydrogen or alkyl of 1 to 3 carbon atoms, or together ##STR3## is pyrrolidino, piperidino or morpholino; wherein R.sub.2 is hydrogen, chlorine or fluorine; wherein R.sub.3 is hydrogen, or fluorine if R.sub.2 is fluorine; wherein R.sub.4 is hydrogen, fluorine, chlorine, bromine, nitro, or trifluoromethyl; and wherein R.sub.5 is hydrogen, methyl or ethyl. These compounds, except those in which R.sub.7 is hydrogen, are produced by heating a compound of formula II: ##STR4## wherein R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are defined as hereinabove, and wherein R'.sub.1 is the same as R.sub.1 except that in defining R'.sub.1,R.sub.7 may not be hydrogen, with aqueous formaldehyde in formic acid solution at reflux temperature (about 100.degree. C.).Compounds in which R.sub.7 are hydrogen require steps further shown in the specification.The compounds of formula I and their pharmacologically acceptable acid addition salts thereof have tranquilizing, anti-anxiety and anti-convulsant activity useful for the treatment of animals and man.

    摘要翻译: 式I的化合物:其中R 1是羟甲基或-CH 2 NR 6 R 7,其中R 6是-CH 2 -C 3 CH 3,CH 2 -CH = CH 2,或者具有1至3个碳原子的烷基,包括 ; R 7是氢或1至3个碳原子的烷基,或者一起是吡咯烷子基,哌啶子基或吗啉代; 其中R2是氢,氯或氟; 其中R 3为氢,或如果R 2为氟,则为氟; 其中R4是氢,氟,氯,溴,硝基或三氟甲基; 并且其中R 5是氢,甲基或乙基。 这些化合物除了R7是氢的化合物之外,是通过加热式II化合物制备的:其中R2,R3,R4和R5如上所定义,并且其中R'1与R1相同,除了 在定义R'1时,R7可能不是氢,甲醛水溶液在甲酸溶液中在回流温度(约100℃)下。

    Derivatives of 4,5,6,7-tetrahydroimidazo-[4,5-c]pyridinyl-6-carboxylic
acid

    公开(公告)号:US5262537A

    公开(公告)日:1993-11-16

    申请号:US33522

    申请日:1993-03-19

    CPC分类号: C07D471/04

    摘要: This invention pertains to a method for treating a condition of nausea and vomiting in a mammal which comprises administering a therapeutically effective amount of a 4,5,6,7-tetrahydroimidazo[4,5-c]pyridinyl-6-carboxylic acid derivative represented by the formula: ##STR1## wherein R.sub.1 and R.sub.2 are hydrogen or lower-alkyl; R.sub.3 is selected from the group consisting of hydrogen, lower-alkyl, nitro, amino, cyano, and alkylmercapto; R.sub.4 and R.sub.5 are selected from the group consisting of hydrogen, lower-alkyl, aryl, and aryl lower-alkyl, or R.sub.4 and R.sub.5 together with the carbon atom to which they are attached form a 5- or 6-member saturated hydrocarbon ring; R.sub.6 is selected from the group consisting of hydrogen, lower-alkyl, aryl lower-alkyl, formyl, lower-alkyl carbonyl, and aryl carbonyl; R.sub.7 is selected from the group consisting of phenyl, thienyl, indolyl, indazolyl, benzo[b]furanyl, benzo[b]thiophenyl, and R.sub.8 R.sub.9 --N--; R.sub.8 is selected from the group consisting of 8-[1,2,3,4,-tetrahydroquinolinyl], pyridinyl, 3-quinolinyl, 2-naphthalinyl, 2-thiazolyl, 2-benzothiazolyl, 4-[2,1,3]benzothiadiazolyl, 2-(4,5,6,7-tetrahydrobenzo)thiazolyl, 7-(2,2-dimethyl-2,3-dihydrobenzo)furanyl, and phenyl; R.sub.9 is hydrogen or lower-alkyl; R.sub.8 R.sub.9 --N-- is selected from the group consisting of 1-indolinyl, 1-(3,3-dimethylindolinyl), and 1-(1,2,3,4-tetrahydroquinolinyl); wherein the groups represented by R.sub.7 other than R.sub.8 R.sub.9 N-- may be unsubstituted or substituted with one or more substituents selected from the group consisting of lower-alkyl, lower-alkoxy, di-lower-alkylamino, and aryloxy, and the groups represented by R.sub.8 and the radical R.sub.8 R.sub.9 N-- may have one or more substituents selected from the group consisting of hydroxy, halogen, lower-alkyl, lower-alkoxy, amino, mono- or di-lower-alkylamino, lower-alkyl carbonyl, lower-alkoxy carbonyl, and aryloxy; wherein each aryloxy group may be unsubstituted or substituted with substituents independently selected from the group consisting of lower-alkyl, lower-alkoxy, halogen, and trifluoromethyl with the proviso that, when R.sub.8 is phenyl, said phenyl group contains at least one substituent.